HWA
REGN icon

HHM Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

HHM Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Hold
20
– – ﹤0.01% 598
2026
Q1 		$15.5K Hold
20
– – ﹤0.01% 551
2025
Q4 		$15.4K Hold
20
– – ﹤0.01% 539
2025
Q3 		$11.2K Hold
20
– – ﹤0.01% 618
2025
Q2 		$10.5K Hold
20
– – ﹤0.01% 604
2025
Q1 		$12.7K Hold
20
– – ﹤0.01% 565
2024
Q4 		$14.2K Hold
20
– – ﹤0.01% 544
2024
Q3 		$21K Hold
20
– – ﹤0.01% 458
2024
Q2 		$21K Hold
20
– – ﹤0.01% 442
2024
Q1 		$19.3K Hold
20
– – ﹤0.01% 418
2023
Q4 		$17.6K Hold
20
– – ﹤0.01% 427
2023
Q3 		$16.5K Hold
20
– – ﹤0.01% 432
2023
Q2 		$14.4K Hold
20
– – ﹤0.01% 466
2023
Q1 		$16.4K Hold
20
– – ﹤0.01% 444
2022
Q4 		$14.4K Hold
20
– – ﹤0.01% 402
2022
Q3 		$14K Hold
20
– – ﹤0.01% 392
2022
Q2 		$12K Hold
20
– – ﹤0.01% 507
2022
Q1 		$14K Hold
20
– – ﹤0.01% 503
2021
Q4 		$13K Sell
20
-125
-86% -$76.9K ﹤0.01% 489
2021
Q3 		$88K Buy
145
+125
+625% +$77.6K 0.02% 221
2021
Q2 		$11K Hold
20
– – ﹤0.01% 469
2021
Q1 		$9K Hold
20
– – ﹤0.01% 456
2020
Q4 		$10K Buy
+20
New +$10.8K ﹤0.01% 419

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HHM Wealth Advisors's REGN Position: Q2 2026 in Review

HHM Wealth Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 20 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

HHM Wealth Advisors first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $88K in Q3 2021. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HHM Wealth Advisors held 20 shares of Regeneron Pharmaceuticals worth $12.5K as of Q2 2026.
  • HHM Wealth Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #598 holding.
  • HHM Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • HHM Wealth Advisors's Regeneron Pharmaceuticals position peaked at $88K in Q3 2021.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.